Evidence map›Paper›PMID 35010916›Full record

Trial reportNutrients2021

An Investigation into the Effects of a Curcumin Extract (Curcugen

Adrian L Lopresti, Stephen J Smith, Shavon Jackson-Michel, Timothy Fairchild

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 6 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 6 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Efficacy and Safety of Curcumin andFrontiers in immunology · 2022
    Pooled it
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Adrian L LoprestiClinical Research Australia, Perth, WA 6023, Australia.
Stephen J SmithClinical Research Australia, Perth, WA 6023, Australia.
Shavon Jackson-MichelDolCas Biotech, LLC, Landing, NJ 07850, USA.
Timothy FairchildCollege of Science, Health, Engineering and Education, Murdoch University, Perth, WA 6150, Australia.ORCID 0000-0002-3975-2213
Murdoch University · AU

Funding

CSRD VA 1
6 · The paper itself

Abstract

Curcumin, a phytochemical from the spice turmeric, has anti-inflammatory properties and has been shown to have pain-relieving effects. In this 8-week, randomised, double-blind, placebo-controlled study, 101 adults with knee osteoarthritis received either 500 mg twice daily of a standardised curcumin extract (Curcugen

Indexed as

AgedAnti-Inflammatory AgentsCurcumaCurcuminDouble-Blind MethodFemaleHumansMaleMiddle AgedOsteoarthritis, KneePainPain MeasurementPlant ExtractsTreatment OutcomeWalk TestAnti-Inflammatory AgentsCurcuminPlant Extractsclinical trialcurcuminkneeosteoarthritisturmeric

Identifiers

PMID35010916
PMCPMC8746505
OpenAlexW4200577121

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.